Study in Subjects Greater Than 40 Years of Age With COPD
Public ClinicalTrials.gov record NCT00507234. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-Week Trial to Compare the Efficacy and Safety of Concomitant Treatment With Formoterol Fumarate Inhalation Solution 20 Mcg Twice Daily and Tiotropium 18 Mcg Once Daily to Tiotropium 18 Mcg Once Daily Alone in the Treatment of Patients With Chronic Obstructive Pulmonary Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a multicenter, Phase IIIb, randomized, double-blind, active-controlled, parallel-group, comparative study. The objectives of this study are: 1. To compare the efficacy of tiotropium 18 mcg once daily plus Formoterol Fumarate Inhalation Solution (FFIS) 20 mcg twice daily to tiotropium 18 mcg once daily. 2. To obtain safety data on the use of tiotropium 18 mcg once daily plus FFIS 20 mcg twice daily compared to tiotropium 18 mcg once daily.
Study identification
- NCT ID
- NCT00507234
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 128 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2007 (Type not available)
- Primary completion
- Oct 2007 (Actual)
- Completion
- Apr 2008 (Actual)
- Last update posted
- Nov 11, 2010
2007 – 2008
United States locations
- U.S. sites
- 19
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Site | Mobile | Alabama | 36695 | — |
| Clinical Research Site | Phoenix | Arizona | 85006 | — |
| Clinical Research Site | DeLand | Florida | 32720 | — |
| Clinical Research Site | Atlanta | Georgia | 30330 | — |
| Clinical Research Site | Livonia | Michigan | 48152 | — |
| Clinical Research Site | Saint Charles | Missouri | 63301 | — |
| Clinical Research Site | St Louis | Missouri | 63141 | — |
| Clinical Research Site | Albany | New York | 12205 | — |
| Clinical Research Site | North Syracuse | New York | 13212 | — |
| Clinical Research Site | Williamsville | New York | 14221 | — |
| Clinical Research Site | Toledo | Ohio | 45560 | — |
| Clinical Research Site | Medford | Oregon | 97504 | — |
| Clinical Research Site | Portland | Oregon | 97213 | — |
| Clinical Research Site | Greenville | South Carolina | 29615 | — |
| Clinical Research Site | Spartanburg | South Carolina | 29303 | — |
| Clinical Research Site | San Antonio | Texas | 78229 | — |
| Clinical Research Site | Abingdon | Virginia | 24210 | — |
| Clinical Research Site | Richmond | Virginia | 23225 | — |
| Clinical Research Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00507234, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 11, 2010 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00507234 live on ClinicalTrials.gov.